Cogent Biosciences, Inc.COGT
Price (close)
$32.31
Market cap
$5.6B
P/E
—
Revenue (TTM)
—
Net income
-$377.2M
Dividend yield
—
1-year total return
143.1%
Net margin
—
Revenue growth
—
Debt / equity
0.42x
What Cogent Biosciences, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $7.9M | — | — | — | — | — |
| Net income | -$74.8M | -$72.3M | -$140.2M | -$192.4M | -$255.9M | -$328.9M |
| Free cash flow | — | -$60.5M | -$125.5M | -$156.4M | -$208.4M | -$266.0M |
More on COGT.
- Cogent Biosciences, Inc. summary
- Cogent Biosciences, Inc. financial statements
- Cogent Biosciences, Inc. key metrics
- Cogent Biosciences, Inc. health scores and style box
- Cogent Biosciences, Inc. earnings
- Cogent Biosciences, Inc. dividends
- Cogent Biosciences, Inc. valuation
- Cogent Biosciences, Inc. ownership and insiders
- Cogent Biosciences, Inc. peers
Figures from Cogent Biosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.